New drugs in clinical stages
Drugs for Degenerative Diseases
Drug for Osteoarthritis
Drug for Animal Osteoarthritis
New drugs in discovery stages
Drug for Immuno-Oncology
Drug for Alzheimer’s Disease
Drug for Type I Diabetes
Animal anti-cancer drug
Bio big data platform
Contract development Services
Contract development services
Material Synthesis & Analysis Services
Home > Customer Center >
Konex market listing
Our company was listed on the Konex market thanks to the great help and interest of our shareholders.
We will do our best to be listed on the KOSDAQ market as soon as possible through successful clinical trials and L/O of our drug pipeline.
Company : Ensol Biosciences Inc. | CEO : Hae-Jin Kim | Business Number : 314-81-39908
Headquarter : 51, Techno 10-ro, Yuseong-gu, Daejeon, 34036, Korea | TEL : +82-42-939-4500 | FAX : +82-42-939-4501
Copyright (c) 2015 Ensol Biosciences Inc. All Rights Reserved.